Alnylam Pharmaceuticals (ALNY) Market Capitalization (2009 - 2026)
Alnylam Pharmaceuticals' Market Capitalization was $33 billion in Q3 2026, down 45.1% from $60.1 billion a year earlier and down 18.0% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Market Capitalization (2009 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Alnylam Pharmaceuticals came in at $52.64 billion, up 73.0% from FY2024.
- Market Capitalization shows a five-year compound annual growth rate of 28.3% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $30.42 billion in FY2024 (+26.4%), $24.08 billion in FY2023 (-18.2%), $29.45 billion in FY2022 (+44.5%) and $20.38 billion in FY2021 (+34.7%).
- The Q3 2026 figure marks the lowest quarterly Market Capitalization since Q4 2024.
- Compared with a year earlier, Market Capitalization was higher in six of the last eight quarters, with growth averaging 33.4%.
- The best year-over-year quarter for Market Capitalization over five years was Q1 2025 (growth of 86.2%); the worst was Q3 2026 (a decline of 45.1%).
- Per Business Quant data, ALNY's Market Capitalization in the three quarters before Q3 2026 was $40.26 billion (Q2 2026), $44.15 billion (Q1 2026) and $52.64 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 33.03 Bn |
| Jun 30, 2026 | 40.26 Bn |
| Mar 31, 2026 | 44.15 Bn |
| Dec 31, 2025 | 52.64 Bn |
| Sep 30, 2025 | 60.10 Bn |
| Jun 30, 2025 | 42.71 Bn |
| Mar 31, 2025 | 35.19 Bn |
| Dec 31, 2024 | 30.42 Bn |
| Sep 30, 2024 | 35.44 Bn |
| Jun 30, 2024 | 31.11 Bn |
| Mar 31, 2024 | 18.90 Bn |
| Dec 31, 2023 | 24.08 Bn |
| Sep 30, 2023 | 22.22 Bn |
| Jun 30, 2023 | 23.72 Bn |
| Mar 31, 2023 | 24.89 Bn |
| Dec 31, 2022 | 29.45 Bn |
| Sep 30, 2022 | 24.62 Bn |
| Jun 30, 2022 | 17.65 Bn |
| Mar 31, 2022 | 19.71 Bn |
| Dec 31, 2021 | 20.38 Bn |
API Access
Alnylam Pharmaceuticals Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();